Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia

J. Kálmán, Indranil Dey, Szöllösiné Varga Ilona, B. Matkovics, Derek Brown, Z. Janka, T. Farkas, Ferenc Joó

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Platelet membrane fluidity (PMF) was measured with three different fluorescent probes, 1,6-diphenyl-1,3,5-hexatriene (DPH), 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH), 3-(p-phenyl-1,3,5-hexatrienyl)phenyl-proprionic acid (DPH-PA), which labeled different parts of the bilayer (the hydrophobic core and the positively and negatively charged regions, respectively) in Alzheimer's disease (AD) patients with and without a family history of dementia, and in a control group. In support of earlier findings in the literature, significantly increased PMF was found by the application of DPH in both groups with AD. The use of the fluorescence probe TMA-DPH, however, revealed no differences between the groups. In contrast, significant rigidification was observed with DPH-PA, but only in the AD group with a positive family history of dementia. The plasma malondialdehyde levels appeared to be similar in each group. Our findings are discussed in light of the controversies regarding the value of PMF measurements in AD.

Original languageEnglish
Pages (from-to)190-194
Number of pages5
JournalBiological Psychiatry
Volume35
Issue number3
DOIs
Publication statusPublished - Feb 1 1994

Fingerprint

Membrane Fluidity
Malondialdehyde
Dementia
Blood Platelets
Alzheimer Disease
Diphenylhexatriene
Fluorescent Dyes
1,3,5-hexatriene
Fluorescence
diphenyl
Control Groups
Acids

Keywords

  • Alzheimer's dementia
  • diphenyl-hexatriene derivatives
  • lipid peroxidation
  • malondialdehyde levels
  • Platelet membrane fluidity

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia. / Kálmán, J.; Dey, Indranil; Varga Ilona, Szöllösiné; Matkovics, B.; Brown, Derek; Janka, Z.; Farkas, T.; Joó, Ferenc.

In: Biological Psychiatry, Vol. 35, No. 3, 01.02.1994, p. 190-194.

Research output: Contribution to journalArticle

@article{f9d347d1bd6d409d940f347fcb4ac745,
title = "Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia",
abstract = "Platelet membrane fluidity (PMF) was measured with three different fluorescent probes, 1,6-diphenyl-1,3,5-hexatriene (DPH), 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH), 3-(p-phenyl-1,3,5-hexatrienyl)phenyl-proprionic acid (DPH-PA), which labeled different parts of the bilayer (the hydrophobic core and the positively and negatively charged regions, respectively) in Alzheimer's disease (AD) patients with and without a family history of dementia, and in a control group. In support of earlier findings in the literature, significantly increased PMF was found by the application of DPH in both groups with AD. The use of the fluorescence probe TMA-DPH, however, revealed no differences between the groups. In contrast, significant rigidification was observed with DPH-PA, but only in the AD group with a positive family history of dementia. The plasma malondialdehyde levels appeared to be similar in each group. Our findings are discussed in light of the controversies regarding the value of PMF measurements in AD.",
keywords = "Alzheimer's dementia, diphenyl-hexatriene derivatives, lipid peroxidation, malondialdehyde levels, Platelet membrane fluidity",
author = "J. K{\'a}lm{\'a}n and Indranil Dey and {Varga Ilona}, Sz{\"o}ll{\"o}sin{\'e} and B. Matkovics and Derek Brown and Z. Janka and T. Farkas and Ferenc Jo{\'o}",
year = "1994",
month = "2",
day = "1",
doi = "10.1016/0006-3223(94)91151-7",
language = "English",
volume = "35",
pages = "190--194",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Platelet membrane fluidity and plasma malondialdehyde levels in Alzheimer's demented patients with and without family history of dementia

AU - Kálmán, J.

AU - Dey, Indranil

AU - Varga Ilona, Szöllösiné

AU - Matkovics, B.

AU - Brown, Derek

AU - Janka, Z.

AU - Farkas, T.

AU - Joó, Ferenc

PY - 1994/2/1

Y1 - 1994/2/1

N2 - Platelet membrane fluidity (PMF) was measured with three different fluorescent probes, 1,6-diphenyl-1,3,5-hexatriene (DPH), 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH), 3-(p-phenyl-1,3,5-hexatrienyl)phenyl-proprionic acid (DPH-PA), which labeled different parts of the bilayer (the hydrophobic core and the positively and negatively charged regions, respectively) in Alzheimer's disease (AD) patients with and without a family history of dementia, and in a control group. In support of earlier findings in the literature, significantly increased PMF was found by the application of DPH in both groups with AD. The use of the fluorescence probe TMA-DPH, however, revealed no differences between the groups. In contrast, significant rigidification was observed with DPH-PA, but only in the AD group with a positive family history of dementia. The plasma malondialdehyde levels appeared to be similar in each group. Our findings are discussed in light of the controversies regarding the value of PMF measurements in AD.

AB - Platelet membrane fluidity (PMF) was measured with three different fluorescent probes, 1,6-diphenyl-1,3,5-hexatriene (DPH), 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH), 3-(p-phenyl-1,3,5-hexatrienyl)phenyl-proprionic acid (DPH-PA), which labeled different parts of the bilayer (the hydrophobic core and the positively and negatively charged regions, respectively) in Alzheimer's disease (AD) patients with and without a family history of dementia, and in a control group. In support of earlier findings in the literature, significantly increased PMF was found by the application of DPH in both groups with AD. The use of the fluorescence probe TMA-DPH, however, revealed no differences between the groups. In contrast, significant rigidification was observed with DPH-PA, but only in the AD group with a positive family history of dementia. The plasma malondialdehyde levels appeared to be similar in each group. Our findings are discussed in light of the controversies regarding the value of PMF measurements in AD.

KW - Alzheimer's dementia

KW - diphenyl-hexatriene derivatives

KW - lipid peroxidation

KW - malondialdehyde levels

KW - Platelet membrane fluidity

UR - http://www.scopus.com/inward/record.url?scp=0028271474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028271474&partnerID=8YFLogxK

U2 - 10.1016/0006-3223(94)91151-7

DO - 10.1016/0006-3223(94)91151-7

M3 - Article

C2 - 8173019

AN - SCOPUS:0028271474

VL - 35

SP - 190

EP - 194

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 3

ER -